1DeRoo LA,Ulastos AT,Mock P,et al. Comparison of women' s breast cancer risk factors in Geneva, Switzerland and Shanghai, China [ J ]. Preventive Medicine, 2010,51 ( 6 ) :497 -501.
2Fisher B, Anderson S, Bryant J, et al. Twenty- year follow up of a ran- domized trial comparing total mastectomy, lumpectomy, and lumpecto- my plus irradiation for the treatment of invasive breast cancer [ J ]. N Engl Med,2002,347(16) :1233-1241.
3Michael S, Sabel. Considerations in Early-Stage Breast Cancer:Lessona Learned and Future Directions [ J ]. Semin Radiat Oncol, 2011,21 (1):10-19.
4Li Zhang, Ming Jiang, Yi Zhou, et al. Survey on breast cancer patients in China toward breast-conserving surgery [ J ]. Psycho-Oncology, 2012,21 (5) :488-495.
7Taghian A, Mohiuddin M ,Jagsi R, et al. Current perceptions regarding Surgical margin status after breast-conserving therapy:resuh of a sur- vey[J]. Ann Sury,2005,241 (4) :629.
8Giuliano AE, McCall L, Beitsch P, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases [ J ]. Ann Surg,2010,252 (3) :426-432.
9Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis [ J ]. JAMA,2011,305 (6) :569-575.
10Darby S, McGale P, Correa C, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death[ J]. Lancet,2011,378 (9804) : 1707-1716.
4Beriwal S, Schwartz GF, Komarnicky L, et al. Breast-conserving thera- py after neoadjuvant chemotherapy:long-term results [ J ]. Breast J, 2006,12(2) :159-164.
5RakhaEA, E1-Sayed ME, Reis-Filho JS, et al. Expression profiling technology:its contribution to our understanding of breast cancer[ J ]. Histopathology,2008,52( 1 ) :67-81.
6Tiezzi DG, Andrade JM, Ribeiro-Silva A, et al. HER-2, p53, p21 and hormonal receptors proteins expression as predictive factors of responseand prognosis in locally advanced breast cancer treated with neoadju- rant docetaxel plus epirubicin combination [ J ]. B MC Cancer,2007,7: 36-46.
7Lee SH, Chung MA, Quddus MR, et al. The effect of neoadjuvant chemotherapy on estrogen and progesterone receptor expression and hormone receptor status in breast cancer [ J ]. Am J Surg, 2003,186 (4) :348-350.
8Tachibana KE, Gonzalez MA, Coleman N. Cell-cycle-dependent regu- lation of DNA replication and its relevance to cancer pathology[ J]. J Patho1,2005,205 ( 2 ) : 123-129.
9Kogure T, Takasaki Y, Takeuchi K, et al. Autoimmune responses to proliferting cell nuclear antigen multiprotein complexes involved in cell in cell proliferation are strongly associated with their structure and bio- logic function in patients with systemic lupus erythematosus [ J ]. Ar- thritis Rheum, 2002,46 ( 11 ) : 2946 -2956.
10Kimos MC, Wang S, Borkowski A, et al. Esophagin and proliferating cell nuclear antigen(PCNA) are biomarkers of human esophageal neo- plastic progression [ J ]. Int J Cancer,2004,111 ( 3 ) :415 -417.
4American College of Radiology. Breast imaging reporting and data system-mammography. In: American College of Radiol- ogy. Breast imaging reporting and data system [ M ] .4th ed. Reston, VA: American College of Radiology,2003.
5Ikeda DM, Birdwell RL, O' shaughnessy KF, et al. Com- puter-aided detection output on 172 subtle findings on nor- mal mammograms previously obtained in women withbreast.cancer detected at follow-up screening mammography [ J ]. Radiology,2004,230(3) : 811-819.
6Warran Burhenne LJ, Wood SA, Orsi C J, et al. The poten- tial contribution of computer-aided detection to the sensitivi- ty of screening mammography [ J ].Radiology,2000,215 (2) : 554- 562.
